| Changing profile of infective endocarditis: results of a 1-year survey in France B Hoen, F Alla, C Selton-Suty, I Béguinot, A Bouvet, S Briançon, ... Jama 288 (1), 75-81, 2002 | 1264 | 2002 |
| Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey C Selton-Suty, M Célard, V Le Moing, T Doco-Lecompte, C Chirouze, ... Clinical infectious diseases 54 (9), 1230-1239, 2012 | 786 | 2012 |
| Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy S Grabar, VL Moing, C Goujard, C Leport, MD Kazatchkine, D Costagliola, ... Annals of internal medicine 133 (6), 401-410, 2000 | 556 | 2000 |
| Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys X Duval, F Delahaye, F Alla, P Tattevin, JF Obadia, V Le Moing, ... Journal of the American College of Cardiology 59 (22), 1968-1976, 2012 | 480 | 2012 |
| The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study V Di Martino, P Rufat, N Boyer, P Renard, S Matheron, V Le Moing, ... Hepatology 34 (6), 1193-1199, 2001 | 422 | 2001 |
| Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial L Bernard, A Dinh, I Ghout, D Simo, V Zeller, B Issartel, V Le Moing, ... The Lancet 385 (9971), 875-882, 2015 | 417 | 2015 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 345 | 2022 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 302 | 2017 |
| The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort P Carrieri, V Cailleton, V Le Moing, B Spire, P Dellamonica, E Bouvet, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (3), 232-239, 2001 | 245 | 2001 |
| The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? A Bannay, B Hoen, X Duval, JF Obadia, C Selton-Suty, V Le Moing, ... European heart journal 32 (16), 2003-2015, 2011 | 236 | 2011 |
| Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort N Néant, G Lingas, Q Le Hingrat, J Ghosn, I Engelmann, Q Lepiller, ... Proceedings of the National Academy of Sciences 118 (8), e2017962118, 2021 | 200 | 2021 |
| Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen V Le Moing, G Chêne, MP Carrieri, A Alioum, F Brun-Vézinet, L Piroth, ... Aids 16 (1), 21-29, 2002 | 193 | 2002 |
| Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis: results of a 1-year survey in France B Hoen, F Alla, C Selton-Suty, I Béguinot, A Bouvet, S Briançon, ... JAmA 288 (1), 75-81, 2002 | 184 | 2002 |
| Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human … M Savès, F Raffi, P Clevenbergh, B Marchou, A Waldner-Combernoux, ... Antimicrobial agents and chemotherapy 44 (12), 3451-3455, 2000 | 169 | 2000 |
| Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study V Le Moing, F Alla, T Doco-Lecompte, F Delahaye, L Piroth, C Chirouze, ... PloS one 10 (5), e0127385, 2015 | 143 | 2015 |
| Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia P Guilpain, C Le Bihan, V Foulongne, P Taourel, N Pansu, ATJ Maria, ... Annals of the rheumatic diseases 80 (1), e10-e10, 2021 | 139 | 2021 |
| Vaccine education of medical students: a nationwide cross-sectional survey S Kernéis, C Jacquet, A Bannay, T May, O Launay, P Verger, C Pulcini, ... American journal of preventive medicine 53 (3), e97-e104, 2017 | 128 | 2017 |
| Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults F Collin, X Duval, V Le Moing, L Piroth, F Al Kaied, P Massip, V Villes, ... Aids 23 (8), 1021-1024, 2009 | 128 | 2009 |
| Prevention of infections during primary immunodeficiency C Aguilar, M Malphettes, J Donadieu, O Chandesris, H Coignard-Biehler, ... Clinical infectious diseases 59 (10), 1462-1470, 2014 | 117 | 2014 |
| Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Antiviral therapy 14 (8), 1065-1074, 2009 | 111 | 2009 |
